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Part 1:

Hepatitis B Vaccination among High-Risk Adults: Results from the National
Health and Examination Survey (NHANES), 2011-2014
Ariel Wilson
University of Mississippi
Mentor: Dr. Hope King
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
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Abstract
Background: Hepatitis B virus (HBV) can be prevented and controlled through
vaccination. However, vaccination among high-risks adults in the U.S. is still low (50%).
This poses serious threats for HBV transmission between infected individuals and highrisk individuals.
Objective: The specific aims of this research were to: (a) explore the prevalence of
hepatitis B vaccination uptake from 2011-2014 (b) to examine intrapersonal,
interpersonal, and organizational level factors associated with receiving hepatitis B
vaccination among high-risk adults.
Methods: Data were analyzed from the National Health and Nutrition Examination
Survey (NHANES) from 2011-2014 to: (1) asses the prevalence of hepatitis B
vaccination and (2) examine the interpersonal, intrapersonal, and organizational level
factors associated with receiving the hepatitis B vaccination among U.S. adults.
Results: Of the 5,379 participants, 464 (weighted 8.6%) were considered high-risk adults
and 4,915 (weighted 91.4%) were considered non-high-risk adults. Overall, vaccination
uptake for high-risk adults was (50.5%) and (53.7%) for non-high risk adults. There
were statistically significant differences between high-risk and non-high-risk based on
race, education, and previous reception of Hep A vaccination.
Discussion: This study illustrated that: (a) hepatitis B vaccination uptake among highrisk adults is improving, but is still less than optimal (b) individual, social, and
environmental factors play a role in receipt of vaccination among high-risk adults. As a
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result, these individual, social, and environmental factors could serve as a driving force to
improve vaccination among high-risk adults.

Conclusion: Efforts to increase access and use of educational programs may
significantly combat certain social and environmental factors that have been linked to low
vaccination rates among high-risk populations. Additionally, the implementation of
stricter ACIP vaccination recommendations should be considered by Federal associations
as a means of increasing vaccination among the general population.
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Introduction:

Hepatitis B is defined as chronic or acute inflammation of the liver caused by the
hepatitis B virus (HBV). Hepatitis B infection is generally spread through percutaneous
or mucosal exposure to infected blood or other bodily fluids (Center for Disease Control
and Prevention, 2006). Due to the likelihood of transmitting HBV to others, individuals
with chronic hepatitis B are considered primary reservoirs for continuous transmission.
Although the development of chronic infection is most often seen in infants and young
children, rates of new infections and acute hepatitis are highest among adults (Center for
Disease Control and Prevention, 2006). Recent findings indicate that: a) 20% of all new
HBV infections in the U.S. are among MSMs. b) 25.8% of new cases are among those
that indicated use of some form of injection drug(s) c) 10% of people with HIV are coinfected with HBV (HIV and Viral Hepatitis, 2014, March), (Statistics and Surveillance,
2016, May 19). The increased probability of contracting Hepatitis B places injection drug
users, men who have sex with men, and HIV positive patients at high-risk.
Since 1982, the hepatitis B vaccine has been recommended for high risk adults,
such as those with a history of sexually transmitted disease (STDs), men who have sex
with men, HIV infected persons, high-risk heterosexuals (e.g.,> multiple sex partners),
and injection drug users. (IDUs) (Center for Disease Control and Prevention, 1982).
Despite standing suggestions and access to universal vaccinations, an estimated 240
million people suffer from chronic hepatitis B globally (Statistics and Surveillance, 2016,
May 19). Americans make up approximately 850,000- 2.2 million of the total cases
worldwide (Roberts et al., 2015).
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Past attempts to combat these numbers, include the 1991 endorsement of a
national strategy to eliminate HBV by the Advisory Committee on Immunization
Practices (ACIP) and other medical organizations (Center for Disease Control and
Prevention, 1991). This strategy called for: 1) screening all pregnant women and
immunizing infants and infected mothers to prevent perinatal transmission 2) universal
vaccination of infants to prevent infections during childhood and at later ages 3)
provision of catch up vaccinations for children and adolescents not previously vaccinated
and 4) vaccination of high risk adults and adolescents. Furthermore, in December 2006,
ACIP updated its recommendations to include the provision of hepatitis B vaccination in
prevention service settings where there is active visitation from unvaccinated, high risk
adults. These settings include: testing and treatment facilities for Human
Immunodeficiency Virus and other Sexually Transmitted Diseases, drug abuse treatment
and prevention settings, health care settings geared toward Injection Drug Users and Men
who have Sex with Men, correctional facilities, chronic hemodialysis facilities and end
stage renal programs, and institutions and nonresidential day care facilities for
developmentally disabled persons (Center for Disease Control and Prevention, 2006).
There has been significant progress in vaccination rates and coverage among
children (92%) and adolescents (67%). However, only 50% of high-risk adults in the
United States (U.S.) have been vaccinated against HBV infection (Lu, Byrd, Murphy, &
Weinbaum, 2011). Such low vaccination rates pose serious threats for the transmission of
hepatitis B virus infection to others.
The specific aims of this research were to: (a) explore the prevalence of hepatitis
B vaccination uptake from 2011-2014 (b) to examine intrapersonal, interpersonal, and
10

organizational level factors associated with receiving hepatitis B vaccination among highrisk adults.
Methods
Data were analyzed from the National Health and Nutrition Examination Survey
(NHANES) from 2011- 2014 to: (1) assess the prevalence of hepatitis B vaccination
uptake and (2) examine the intrapersonal, interpersonal, and organizational level factors
that may be associated with receiving the hepatitis B vaccination among U.S. adults. A
high-risk adult was defined as any adult reporting at least one of the following: a sexually
transmitted infection in the past 12 month (e.g., herpes, chlamydia, gonorrhea, or genital
warts), sex with another man is male, infection with HIV, or past or current injection drug
use. All other adults were classified as non- high-risk. A literature review was performed
to collect information regarding the correlation between high-risk individuals and
vaccination rates and the factors that influence the two. Publications dates were limited
to the year(s) 2011-2016.
Results
Table 1 shows the sample characteristics of adults, aged 18-49 years for the 2011 to
2014-time period. A total of 5,379 adults aged 18-49 years were interviewed. Of the
5,379 participants, 464 (weighted 8.6%) were considered high risk adults and 4,915
(weighted 91.4%) were considered non-high-risk adults. The majority of the sample was
non-Hispanic White (58.7%), female sex (50.6%), between the ages 21-40 (61.2%),
married (49.0%), had greater than a high school education (64.7%), lived at or above the
poverty line (78.5%), and had health insurance (74.3%).
Table 1 Sample Characteristics of Adult, Aged 18-49 Years, NHANES 2011-2014
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High-Risk vs Non-High-Risk
Sample N [Weighted col % (95%CI)]
Factors

Among All-Adults

High-Risk (n=584)

Non-High-Risk (n=5909)

5379 [ 100.0 (. -. ) ]

464 [ 100.0 (.-.) ]

4915 [ 100.0 (. -. ) ]

complete 3 doses

2924 [ 53.4 ( 51.4 -55.4 ) ]

250 [ 50.5 (45.1 -55.9) ]

2674 [53.7 ( 51.6 -55.8 ) ]

no doses

2455 [ 46.6 ( 44.6 -48.6 ) ]

214 [ 49.5 (44.1 -54.9) ]

2241 [46.3 (44.2 -48.4 ) ]

Male

3163 [ 49.4 ( 48.1 -50.7 ) ]

265 [ 47.1 ( 40.8 -53.5 ) ]

2898 [ 49.7 ( 48.2 -51.1 ) ]

Female

3330 [ 50.6 ( 49.3 -51.9 ) ]

319 [ 52.9 ( 46.5 -59.2 ) ]

3011 [ 50.3 ( 48.9 -51.8 ) ]

18-20

875 [ 10.1 ( 8.7 -11.7 ) ]

45 [ 5.5 ( 3.5 -8.4 ) ]

830 [ 10.6 ( 9.2 -12.2 ) ]

21-25

1025 [ 16.5 ( 14.5 -18.6 ) ]

93 [ 15.8 ( 11.4 -21.4 ) ]

932 [ 16.6 ( 14.6 -18.7 ) ]

26-30

918 [ 14.8 ( 13.1 -16.6 ) ]

86 [ 14.6 ( 11.4 -18.5 ) ]

832 [ 14.8 ( 13.0 -16.7 ) ]

31-40

1955 [ 29.9 ( 28.3 -31.6 ) ]

170 [ 28.2 ( 23.6 -33.3 ) ]

1785 [ 30.1 ( 28.3 -32.0 ) ]

41-49

1720 [ 28.7 ( 26.3 -31.3 ) ]

190 [ 35.9 ( 30.3 -41.8 ) ]

1530 [ 27.9 ( 25.4 -30.5 ) ]

NH-White

2335 [ 58.7 ( 53.0 -64.2 ) ]

280 [ 69.9 ( 63.3 -75.8 ) ]

2055 [ 57.4 ( 51.6 -63.0 ) ]

NH-Black

1455 [ 12.6 ( 9.8 -16.1 ) ]

154 [ 13.1 ( 9.1 -18.5 ) ]

1301 [ 12.6 ( 9.9 -16.0 ) ]

Mexican American

901 [ 11.7 ( 9.0 -15.2 ) ]

50 [ 6.5 ( 4.4 -9.6 ) ]

851 [ 12.4 ( 9.4 -16.1 ) ]

1802 [ 16.9 ( 14.7 -19.2 ) ]

100 [ 10.5 ( 8.0 -13.7 ) ]

1702 [ 17.6 ( 15.4 -20.1 ) ]

<=High school

2280 [ 35.3 ( 31.7 -39.0 ) ]

196 [ 34.8 ( 28.6 -41.6 ) ]

2084 [ 35.3 ( 31.8 -39.0 ) ]

>High school

3561 [ 64.7 ( 61.0 -68.3 ) ]

352 [ 65.2 ( 58.4 -71.4 ) ]

3209 [ 64.7 ( 61.0 -68.2 ) ]

2687 [ 49.0 ( 45.7 -52.3 ) ]

186 [ 38.7 ( 31.8 -46.1 ) ]

2501 [ 50.3 ( 47.2 -53.3 ) ]

616 [ 10.5 ( 9.4 -11.7 ) ]

70 [ 13.1 ( 10.2 -16.6 ) ]

546 [ 10.2 ( 8.9 -11.6 ) ]

Overall

HB3Dose

Gender

Age Grp

Race

Others

Edu

Marital
Married
widowed/divorced/sep
arated

12

High-Risk vs Non-High-Risk
Sample N [Weighted col % (95%CI)]
Factors

Among All-Adults

High-Risk (n=584)

Non-High-Risk (n=5909)

2540 [ 40.5 ( 36.6 -44.5 ) ]

292 [ 48.2 ( 41.1 -55.4 ) ]

2248 [ 39.5 ( 35.8 -43.4 ) ]

<=1

1736 [ 21.6 ( 18.1 -25.4 ) ]

164 [ 19.9 ( 15.2 -25.5 ) ]

1572 [ 21.8 ( 18.3 -25.6 ) ]

1-4.99

3302 [ 57.4 ( 53.9 -60.8 ) ]

306 [ 58.3 ( 50.9 -65.4 ) ]

2996 [ 57.3 ( 54.0 -60.5 ) ]

>=5

952 [ 21.1 ( 17.8 -24.7 ) ]

86 [ 21.8 ( 16.2 -28.7 ) ]

866 [ 21.0 ( 17.7 -24.6 ) ]

Yes

4549 [ 74.3 ( 71.8 -76.7 ) ]

421 [ 77.8 ( 71.7 -83.0 ) ]

4128 [ 73.9 ( 71.3 -76.3 ) ]

No

1935 [ 25.7 ( 23.3 -28.2 ) ]

161 [ 22.2 ( 17.0 -28.3 ) ]

1774 [ 26.1 ( 23.7 -28.7 ) ]

clinic or health center

1196 [ 21.3 ( 18.6 -24.3 ) ]

98 [ 20.7 ( 14.0 -29.6 ) ]

1098 [ 21.4 ( 18.9 -24.1 ) ]

doctor office or HMO

3285 [ 71.0 ( 67.8 -74.0 ) ]

324 [ 71.8 ( 62.9 -79.3 ) ]

2961 [ 70.9 ( 67.8 -73.8 ) ]

hospital emergency
room

288 [ 4.7 ( 3.8 -5.8 ) ]

31 [ 4.6 ( 2.8 -7.5 ) ]

257 [ 4.7 ( 3.8 -5.8 ) ]

hospital outpatient
department

68 [ 1.1 ( 0.8 -1.5 ) ]

6 [ 0.6 ( 0.2 -1.5 ) ]

62 [ 1.2 ( 0.8 -1.6 ) ]

100 [ 1.9 ( 1.4 -2.7 ) ]

12 [ 2.2 ( 1.3 -3.8 ) ]

88 [ 1.9 ( 1.4 -2.7 ) ]

None

1426 [ 21.3 ( 19.7 -23.0 ) ]

81 [ 12.8 ( 10.4 -15.7 ) ]

1345 [ 22.3 ( 20.5 -24.2 ) ]

one time

1520 [ 23.6 ( 22.2 -25.2 ) ]

117 [ 19.9 ( 16.2 -24.3 ) ]

1403 [ 24.1 ( 22.4 -25.8 ) ]

2-3 time

1778 [ 29.9 ( 28.6 -31.4 ) ]

159 [ 31.5 ( 26.8 -36.5 ) ]

1619 [ 29.8 ( 28.3 -31.3 ) ]

4-9 time

890 [ 15.4 ( 14.4 -16.5 ) ]

110 [ 21.0 ( 17.0 -25.6 ) ]

780 [ 14.8 ( 13.6 -16.0 ) ]

554 [ 9.7 ( 8.7 -10.8 ) ]

71 [ 14.8 ( 11.5 -18.9 ) ]

483 [ 9.1 ( 8.1 -10.2 ) ]

1-2 doses

2610 [ 44.9 ( 43.0 -46.8 ) ]

229 [ 45.5 ( 39.7 -51.3 ) ]

2381 [ 44.8 ( 42.6 -47.0 ) ]

no doses

2840 [ 55.1 ( 53.2 -57.0 ) ]

257 [ 54.5 ( 48.7 -60.3 ) ]

2583 [ 55.2 ( 53.0 -57.4 ) ]

Never married

Poverty

INSURANCE

CarePlace

some other place

CareTime

>=10 time

HEPADose
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Table 2 shows the factors associated with hepatitis B vaccination vaccine uptake greater
than three doses for ages 18-49 years for the 2011-2014 time period. Overall, vaccination
uptake for high-risk adults was (50.5%) and (53.7%) for non-high risk adults. There was
statistical significance differences seen between high-risk and non-high risk by race,
education, and previous reception of hepatitis A vaccination. There was no statistical
significance differences seen between high-risk and non-risk by race, age group, gender,
marital status, socioeconomic status, insurance, care place or care time.

TABLE 2 – Factors

Associated with Hepatitis B Vaccination Uptake by High-Risk Status and
Individual, Intrapersonal, and Organizational Characteristics, NHANES, 20011-2014
High-Risk

Non-High-Risk

High-Risk with Sample N [Weighted % (95%CI)]

Non-High-Risk with Sample N [Weighted % (95%CI)]

N(col%)

Uptake>=3 dose n(row%)

N(col%)

Uptake>=3 dose n(row%)

Pvalue

464 [ 100.0 ( . -. ) ]

250 [ 50.5 ( 45.1 -55.9 ) ]

4915 [ 100.0 ( . -. ) ]

2674 [ 53.7 ( 51.6 -55.8 ) ]

0.268

Male

205 [ 46.4 ( 39.6 -53.3 ) ]

102 [ 43.6 ( 35.5 -52.1 ) ]

2413 [ 49.5 ( 47.8 -51.3 ) ]

1210 [ 48.8 ( 46.1 -51.4 ) ]

0.225

Female

259 [ 53.6 ( 46.7 -60.4 ) ]

148 [ 56.5 ( 49.1 -63.6 ) ]

2502 [ 50.5 ( 48.7 -52.2 ) ]

1464 [ 58.6 ( 55.7 -61.4 ) ]

0.550

18-20

35 [ 5.8 ( 3.5 -9.5 ) ]

27 [ 84.4 ( 60.2 -95.0 ) ]

692 [ 10.8 ( 9.3 -12.6 ) ]

543 [ 78.3 ( 72.9 -82.8 ) ]

0.488

21-25

76 [ 17.0 ( 12.6 -22.6 ) ]

53 [ 67.6 ( 53.7 -79.0 ) ]

766 [ 16.1 ( 14.2 -18.3 ) ]

549 [ 72.7 ( 67.9 -77.0 ) ]

0.464

26-30

63 [ 14.0 ( 10.6 -18.3 ) ]

36 [ 55.0 ( 39.5 -69.7 ) ]

684 [ 14.6 ( 12.8 -16.7 ) ]

412 [ 64.2 ( 59.6 -68.6 ) ]

0.254

31-40

136 [ 28.7 ( 23.8 -34.3 ) ]

68 [ 45.7 ( 37.5 -54.2 ) ]

1464 [ 29.7 ( 27.9 -31.6 ) ]

685 [ 46.5 ( 43.5 -49.5 ) ]

0.862

41-49

154 [ 34.5 ( 29.0 -40.4 ) ]

66 [ 38.5 ( 27.3 -51.1 ) ]

1309 [ 28.7 ( 26.0 -31.5 ) ]

485 [ 35.8 ( 32.2 -39.6 ) ]

0.646

220 [ 70.2 ( 63.1 -76.4 ) ]

107 [ 47.3 ( 40.6 -54.0 ) ]

1737 [ 58.3 ( 52.5 -63.9 ) ]

941 [ 54.4 ( 51.7 -57.1 ) ]

0.046
3*

Factors

Overall

Gender

Age Grp

Race
NH-White
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High-Risk

Non-High-Risk

High-Risk with Sample N [Weighted % (95%CI)]

Non-High-Risk with Sample N [Weighted % (95%CI)]

N(col%)

Uptake>=3 dose n(row%)

N(col%)

Uptake>=3 dose n(row%)

Pvalue

129 [ 14.0 ( 9.6 -19.9 ) ]

76 [ 57.4 ( 46.1 -68.0 ) ]

1130 [ 13.1 ( 10.2 -16.6 ) ]

649 [ 56.7 ( 52.4 -60.8 ) ]

0.897

Mexican
American

37 [ 5.9 ( 3.9 -8.7 ) ]

17 [ 46.7 ( 32.1 -61.8 ) ]

665 [ 11.6 ( 8.7 -15.2 ) ]

292 [ 43.2 ( 37.4 -49.2 ) ]

0.688

Others

78 [ 10.0 ( 7.5 -13.3 ) ]

50 [ 65.8 ( 55.2 -75.0 ) ]

1383 [ 17.1 ( 15.0 -19.4 ) ]

792 [ 56.1 ( 52.6 -59.6 ) ]

0.083
4

<=High
school

150 [ 34.6 ( 28.3 -41.5 ) ]

76 [ 50.8 ( 41.0 -60.6 ) ]

1715 [ 34.8 ( 31.0 -38.8 ) ]

703 [ 41.1 ( 38.0 -44.4 ) ]

0.042
3*

>High
school

286 [ 65.4 ( 58.5 -71.7 ) ]

153 [ 48.3 ( 41.3 -55.5 ) ]

2685 [ 65.2 ( 61.2 -69.0 ) ]

1567 [ 57.7 ( 55.0 -60.4 ) ]

0.011
3*

Married

143 [ 37.1 ( 30.2 -44.6 ) ]

70 [ 45.5 ( 33.9 -57.6 ) ]

2057 [ 49.9 ( 46.6 -53.1 ) ]

981 [ 48.1 ( 44.7 -51.5 ) ]

0.648

widowed/di
vorced/separate
d

59 [ 13.7 ( 10.4 -17.8 ) ]

28 [ 37.3 ( 22.6 -54.7 ) ]

462 [ 10.4 ( 9.1 -11.9 ) ]

216 [ 43.3 ( 36.7 -50.1 ) ]

0.505

Never
married

234 [ 49.2 ( 42.1 -56.3 ) ]

131 [ 55.3 ( 46.0 -64.3 ) ]

1884 [ 39.7 ( 35.9 -43.7 ) ]

1074 [ 59.1 ( 54.8 -63.2 ) ]

0.422

<=1

132 [ 20.3 ( 15.5 -26.1 ) ]

68 [ 51.1 ( 38.6 -63.4 ) ]

1303 [ 21.7 ( 18.2 -25.6 ) ]

754 [ 58.4 ( 53.8 -62.9 ) ]

0.216

1-4.99

238 [ 57.8 ( 50.5 -64.8 ) ]

133 [ 51.1 ( 43.5 -58.8 ) ]

2492 [ 57.2 ( 53.8 -60.6 ) ]

1327 [ 51.6 ( 49.0 -54.2 ) ]

0.906

>=5

71 [ 21.9 ( 16.5 -28.4 ) ]

35 [ 47.9 ( 34.3 -61.9 ) ]

725 [ 21.1 ( 17.7 -24.9 ) ]

397 [ 55.5 ( 51.4 -59.6 ) ]

0.254

Yes

333 [ 76.8 ( 70.1 -82.4 ) ]

186 [ 52.4 ( 45.0 -59.7 ) ]

3449 [ 74.1 ( 71.4 -76.6 ) ]

2002 [ 56.7 ( 54.4 -59.0 ) ]

0.265

No

131 [ 23.2 ( 17.6 -29.9 ) ]

64 [ 44.2 ( 34.3 -54.7 ) ]

1463 [ 25.9 ( 23.4 -28.6 ) ]

671 [ 45.0 ( 41.1 -49.0 ) ]

0.875

clinic or
health center

77 [ 20.6 ( 12.9 -31.2 ) ]

49 [ 54.4 ( 43.2 -65.1 ) ]

915 [ 21.1 ( 18.3 -24.2 ) ]

481 [ 51.6 ( 47.0 -56.2 ) ]

0.631

doctor office
or HMO

264 [ 72.1 ( 61.4 -80.7 ) ]

145 [ 51.5 ( 42.0 -60.8 ) ]

2500 [ 71.2 ( 67.7 -74.5 ) ]

1454 [ 56.4 ( 53.9 -58.9 ) ]

0.276

Factors
NH-Black

Edu

Marital

Poverty

INSURANCE

CarePlace

15

High-Risk

Non-High-Risk

High-Risk with Sample N [Weighted % (95%CI)]

Non-High-Risk with Sample N [Weighted % (95%CI)]

N(col%)

Uptake>=3 dose n(row%)

N(col%)

Uptake>=3 dose n(row%)

Pvalue

hospital
emergency
room

26 [ 5.1 ( 2.9 -8.8 ) ]

12 [ 39.1 ( 22.8 -58.1 ) ]

217 [ 4.7 ( 3.6 -6.0 ) ]

109 [ 49.6 ( 43.2 -55.9 ) ]

0.316

hospital
outpatient
department

5 [ 0.7 ( 0.2 -1.8 ) ]

4 [ 62.0 ( 13.8 -94.3 ) ]

51 [ 1.1 ( 0.7 -1.6 ) ]

30 [ 63.9 ( 49.6 -76.1 ) ]

0.943

some other
place

7 [ 1.6 ( 0.8 -3.1 ) ]

4 [ 48.5 ( 17.4 -80.8 ) ]

74 [ 1.9 ( 1.4 -2.8 ) ]

43 [ 55.4 ( 42.8 -67.4 ) ]

0.736

None

67 [ 14.2 ( 11.4 -17.6 ) ]

25 [ 36.6 ( 25.1 -49.8 ) ]

1098 [ 21.9 ( 20.2 -23.7 ) ]

519 [ 46.7 ( 42.7 -50.8 ) ]

0.140
0

one time

92 [ 20.8 ( 15.9 -26.8 ) ]

55 [ 53.6 ( 40.2 -66.5 ) ]

1162 [ 23.9 ( 22.1 -25.8 ) ]

643 [ 53.7 ( 49.8 -57.7 ) ]

0.981

2-3 time

122 [ 29.6 ( 24.7 -35.0 ) ]

69 [ 52.0 ( 42.2 -61.6 ) ]

1342 [ 29.7 ( 28.0 -31.5 ) ]

749 [ 54.2 ( 50.9 -57.3 ) ]

0.674

4-9 time

88 [ 20.3 ( 16.1 -25.2 ) ]

52 [ 61.3 ( 48.0 -73.0 ) ]

651 [ 15.0 ( 13.6 -16.6 ) ]

374 [ 58.6 ( 53.2 -63.7 ) ]

0.710

>=10 time

60 [ 15.1 ( 11.6 -19.4 ) ]

32 [ 46.2 ( 31.5 -61.5 ) ]

413 [ 9.4 ( 8.4 -10.5 ) ]

246 [ 59.0 ( 52.8 -65.0 ) ]

0.114
7

1-2 doses

200 [ 44.5 ( 38.5 -50.7 ) ]

172 [ 80.7 ( 72.9 -86.7 ) ]

2181 [ 44.1 ( 41.7 -46.5 ) ]

1960 [ 89.2 ( 87.3 -90.7 ) ]

0.011
6*

no doses

232 [ 55.5 ( 49.3 -61.5 ) ]

64 [ 29.0 ( 22.7 -36.3 ) ]

2433 [ 55.9 ( 53.5 -58.3 ) ]

516 [ 23.8 ( 21.3 -26.4 ) ]

0.165
7

Factors

CareTime

HEPADose

Discussion
Hepatitis B can be prevented through vaccination. Among high risk adults the prevalence
of hepatitis B vaccination had a slight increase from 47.0% in 2007-2010 to 51.0% in
2011-2014.

This study illustrated that hepatitis B vaccination uptake among high-risk

adults is getting better but is still less than optimal. Although hepatitis B vaccination
uptake was relatively low, this study illustrated that individual, social, and environmental

16

factors play a role in receipt of vaccination among high-risk adults. As a result, these
individual, social, and environmental factors could serve as driving forces to improve
vaccination coverage among high-risk adults. Thus strategies to promote education about
hepatitis B vaccination among high risk adults could assist with increasing vaccination
rates.
Conclusion
Programs established by public health officials to be implemented in local health
departments, educational environments (i.e. high-schools or universities), and specific
areas where high-risk populations are prominent should be strongly considered. Efforts to
increase access and use of educational programs may significantly combat certain social
and environmental factors that have been linked to low vaccination rates among high-risk
populations. In addition to educational efforts, updated ACIP recommendation strategies
that call for stricter vaccination practices among the general population may also lead to
an overall increase in the rate of Hepatitis B vaccination uptake.
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Abstract:
Background: Hepatitis B is a completely preventable disease. However, the rise in
highly educated, middle class, anti-vaccine communities has increased the fear of
government officials that infectious diseases that could be potentially eradicated will
reappear or rise in prevalence.
Objective: The purpose of this study was to determine the degree of the influence of
education on:
1. hepatitis B knowledge and awareness regarding the general understanding of the
infection, hepatitis B preventability, and hepatitis B transmission.
2. vaccine use as a preventative measure for hepatitis B and other life threatening,
preventable diseases.
3. beliefs regarding parental decisions to vaccinate children
Methods: Data were analyzed to determine the existence of a correlational relationship
between education and (a) knowledge and awareness regarding the general understanding
of the infection, hepatitis B preventability, and hepatitis B transmission (b) vaccine use as
a preventative measure for hepatitis B and other life threatening, preventable diseases (c)
beliefs regarding parental decisions to vaccinate
Results: The total sample consisted of sixteen freshmen, (13.01%), twenty-six
sophomores (21.14%), thirty juniors (24.39%), thirty-three seniors (26.83%), and
eighteen graduate students (14.63%). There were statistically significant differences
between familiarity with hepatitis B based on classification and some evidence that
science majors may be more knowledgeable of hepatitis B.
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Discussion: An increase in the number of U.S. parents and educated individual
expressing opposition to vaccinations against Hepatitis B and other infectious diseases
poses a significant threat of the re-introduction of infectious diseases among nonvaccinated populations.
Conclusion: A lack of knowledge and awareness of hepatitis B infection and
transmission and vaccine use among highly educated students indicates the need for the
implementation of specific educational programs at the University of MS directed
towards; (a) increasing knowledge and awareness of preventable diseases, such as
hepatitis B, (b) minimizing social stigmas associated with these topics, and (c)
encouraging and increasing the use of strong educational backgrounds, specifically in
science related subjects, to motivate others to consider the risk side of infectious diseases
even when the symptoms are not visible.
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Introduction:

In 2014, there were an estimated 19,200 new hepatitis B virus infections in the
United States. In the United States, an estimated 850,000-2.2 million persons have
chronic hepatitis B. Globally, chronic hepatitis B affects approximately 240 million
people and contributes to an estimated 786,000 deaths each year (Centers for Disease
Control and Prevention, 2016). Most people who are diagnosed with chronic hepatitis B
were infected at birth or during early childhood. It is reported that approximately 90% of
infected infants will develop a chronic infection (Centers for Disease Control and
Prevention, 2016). Although the risk goes down as a child gets older approximately
25%–50% of children infected between the ages of 1 and 5 years will develop chronic
hepatitis. (Centers for Disease Control and Prevention, 2016). Children with chronic
hepatitis B may display no physical signs or symptoms of chronic infection making it
very difficult to detect. These children are at increased risk for developing serious liver
problems like cirrhosis or liver cancer. (Children’s Hospital of Philadelphia, 2013).
Since 1982, the hepatitis B vaccine has been recommended for high risk adults,
such as those with a history of sexually transmitted disease (STDs), men who have sex
with men (MSMs), HIV infected persons, high-risk heterosexuals (e.g.,>multiple sex
partners), and injection drug users (IDUs) (Centers for Disease Control and Prevention,
1982). In 1991 the Advisory Committee on Immunization Practices (ACIP) endorsed a
national strategy to eliminate HBV (Centers for Disease for Control and Prevention,
1991). This strategy called for: 1) screening all pregnant women and immunizing infants
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and infected mothers to prevent perinatal transmission 2) universal vaccinations for
children and adolescents not previously vaccinated and 3) vaccination of high risk adults
and adolescents. In 1995, ACIP recommended the routine vaccination of adolescents 1112 years who had not been vaccinated previously and in 1999, ACIP recommended that
all unvaccinated children aged <19 years be vaccinated (Centers for Disease Control and
Prevention, 2002). Furthermore, in December 2006, ACIP updated its recommendations
to include the prevision of hepatitis B vaccination in prevention service settings where
there is active visitation from unvaccinated, high risk adults. These settings include:
testing and treatment facilities for Human Immunodeficiency Virus and other Sexually
Transmitted Diseases, drug abuse treatment and prevention settings, health care setting
geared toward injection drug users and men who have sex with men, correctional
facilities, chronic hemodialysis facilities and end stage renal programs, and institutions
and nonresidential day care facilities for developmentally disabled person (Centers for
Disease Control and Prevention, 2006).
Nonetheless, the ACIP vaccination strategies for children and adolescents have
been implemented successfully in the United States, and hepatitis B is now considered
part of the routine childhood vaccination schedule (Centers for Disease Control and
Prevention, 2002). During the years 1993-2000, the national coverage rates for hepatitis
B vaccine among children 19-35 months increased from 16% to 90% and the coverage
rate for U.S. adolescents aged 13-15 years increased from near zero to 67%. (Centers for
Disease Control and Prevention, 2002). The rate of this success of modern ACIP
recommendations is often associated with: (a) the enactment of the national program,
Vaccines for Children, in 1994, which purchases ACIP- recommended vaccines for
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eligible children aged <19 years, (b) the enactment of laws mandating hepatitis B
vaccination for children entering elementary school and childcare centers in forty-four
states and requiring vaccinations for adolescents in middle school in thirty-four states.
(Centers for Disease Control and Prevention, 2002)
In July of 2016, The Centers for Disease Control and Prevention’s National
Center for Immunization and Respiratory Diseases updated its original statement that the
best protection against hepatitis B is by getting the hepatitis B vaccine (Centers for
Disease Control and Prevention, 2014). Doctors recommended that all parents vaccinate
their child/children to: (a) protect their child/children against hepatitis B (b) protect other
people from the disease because children with hepatitis B usually don’t have symptoms,
but they often pass the disease to others without anyone knowing they were infected. (c)
prevent their child from liver disease and cancer from hepatitis B. and (d) keep their child
from missing school or childcare (Centers for Disease Control and Prevention, 2014).
According to the Centers for Disease Control and Prevention, the hepatitis B vaccine is
very safe and effective at preventing hepatitis B; like any medicine, the vaccine, can have
side effects. However, no serious side effects are known to be caused by the hepatitis B
vaccine (Center for Disease Control and Prevention, 2014). To further address parental
concerns regarding the vaccination of their infant(s), the National Center for
Immunization released the following statement,
“It’s hard to imagine putting your newborn through the pain of a shot. But a
little stick early in life is an important first step to protecting your baby against a deadly
disease. All babies should get the first shot of hepatitis B vaccine before they leave the
hospital. This shot acts as a safety net, reducing the risk of getting the disease from
moms or family members who may not know they are infected with hepatitis B. When a
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mom has hepatitis B, there’s an additional medicine that can help protect the baby
against hepatitis B, called the hepatitis B immune globulin (HBIG). HBIG gives a baby’s
body a “boost” or extra help to fight the virus as soon as he/she is born. This shot works
best when the baby gets it within the first 12 hours of his/her life. The baby will also need
to complete the full hepatitis vaccination series for best protection”. (Centers for
Disease Control and Prevention, 2014)

Despite standing ACIP and CDC recommendations, laws, and recent statistical
findings that support the notion of hepatitis B vaccination among infants, an increasing
number of U.S. parents are expressing opposition to current hepatitis B vaccine
regulations. Parents across the U.S. have contacted the National Vaccine Information
Center (NVIC) to report their opposition to hepatitis B regulations being enacted by their
state health departments officials. (National Vaccine Information Center, 1998).
Previously reported reasons for parental opposition include: (a) Hepatitis is B not highly
contagious (b) Hepatitis B is not a killer disease for most (c) Hepatitis B is low in the
U.S. (d) Federal health officials give state health officials money to force hepatitis B
Vaccination (e) The pharmaceutical industry also funds forced hepatitis B
vaccination (f) Pharmacist now vaccinate (g) Families are now being penalized for
refusing hepatitis B vaccine (h) Hepatitis B vaccine is licensed by the FDA without
adequate proof of long term safety (i) Hepatitis B efficacy has been questioned (j)
The Institute of Medicine report reveals lack of adequate scientific studies (k)
Medical literature cites immune system/brain damage and (l) Vaccine injuries have
been reported at the National Vaccine Information Center. (National Vaccine
Information Center, 1998). As a result of parental opposition, an increasing number of
schools and employers are pressured from government health officials to require
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individuals to provide proof of hepatitis B vaccination before being allowed to enter work
places or schools. This rise in opposition by educated parents may lead to a rise in U.S.
parents who choose to use religious or health related exemptions that permit attendance
in public/private schools systems without few or all recommended vaccines.
The Centers for Disease Control and Prevention has discovered certain
communities with a large population of parents who either do not vaccinate their children
or pick and choose which vaccines to permit and how they are scheduled (Public
Broadcasting Service, 2014). The 2015 Frontline Public Broadcasting Service (PBS)
documentary, The Vaccine War, highlights a cluster of Americans in Ashland Oregon, a
community of financially advantaged, educated individuals, who strongly oppose the
vaccination of their young children. Since 2010, parents from the Ashland community
have gradually increased their dismissal of vaccine use. Because of the existence of
vaccine exemptions, some 28% of Ashland’s kids are allowed to attend public schools
lacking some or all of their required vaccinations (Public Broadcasting Service, 2014). As
a result, it now has one of the lowest vaccination rates in the country. The rise in highly
educated, middle class anti-vaccine communities like Ashland has increased fears of
government officials that diseases like hepatitis B and many others that could be
potentially eradicated will reappear (Public Broadcasting Service, 2014).

According to previous findings by the Centers for Disease Control and Preventions
Division of Viral Hepatitis, individual, social and environmental factors may play a role
in the uptake of hepatitis B vaccinations and hepatitis B vaccine opposition (Centers for
Disease Control and Prevention, 2016). In addition, these findings also indicate that
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strategies to promote education about hepatitis B vaccination could assist with reducing
opposition and decreasing the influence of negative stigmas regarding hepatitis B
vaccination.
The purpose of this study was to determine the degree of the influence of
education on:
4. hepatitis B knowledge and awareness regarding the general understanding of the
infection, hepatitis B preventability, and hepatitis B transmission.
5. vaccine use as a preventative measure for hepatitis B and other life threatening,
preventable diseases.
6. beliefs regarding parental decisions to vaccinate children
Methods:
Data were analyzed to determine the existence of a correlational relationship between
education and (a) knowledge and awareness regarding the general understanding of the
infection, hepatitis B preventability, and hepatitis B transmission (b) vaccine use as a
preventative measure for hepatitis B and other life threatening, preventable diseases (c)
beliefs regarding parental decisions to vaccinate. All subjects were eighteen or older and
currently enrolled as part-time or full-time students at one of six University of
Mississippi campuses. Recruitment for sample participants involved the use of social
media (i.e. posting flyers on specific class social media pages), email distribution, in class
announcements to students, posting flyers on club and organization newsfeeds, and a
randomized sampling collection by the University of Mississippi’s Institutional Review
Board.
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Tables 1 and 2 were classified using a 2-way classification table and tables 1, 2, 3, 5, and
6 were evaluated using a 95% conference interval. Sample proportions for classification
tables 2, 3, 5, and 6 were assessed using a sample tests for equality of proportions with
continuity correction and table 1 was assessed using a sample test for equality of
proportions without continuity correction. A 10% significance level was used during the
analysis of table 1 to account for any possible limitations associated with population size.
Lastly, table 4 was assessed using a Fisher’s exact test for count data.
Results:
Knowledge and Awareness of Hepatitis B and Vaccine Uptake Among University of
Mississippi Students
Graph A

Student response to familiarity question

Q: Are you familiar with Hepatitis B?

Percentage of students familiar with Hep B

The graph above illustrated the overall familiarity of hepatitis B among University of
Mississippi students. Seventy-nine respondents (64.75%) reported they were familiar
with Hepatitis B and forty-three respondents (35.25%) reported they were not familiar
with hepatitis B.
28

Student Response to Hep B
definition

Graph B
Q: If familiar, which of the following best aligns with your definition of Hepatitis B?

Percentage of students by definition of Hep B
The graph above illustrates students’ responses to the definition of hepatitis B.
Eighty-one students (84.38%) chose the correct response, hepatitis B is a viral infection
that attacks liver, twelve students (12.50%) responded hepatitis B is a viral infection that
attacks the kidneys, three students (3.13%) reported hepatitis B is a viral infection that
attacks the spleen.
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Graph C

Student response to previous
Hep B vaccination

Q: Have you previously received any vaccination against the Hepatitis B Virus?

Percent of students knowledgeable of previous Hep B Vaccination

The graph above illustrates the number of individual who are aware of their
current hepatitis B vaccination status. Fifty-seven students (47.1%) reported they had
previously received the hepatitis B vaccine, twenty students (16.5%) reported they had
not previously received the hepatitis B vaccine, and forty-four (36.4%) reported they
were unaware of their hepatitis B vaccination status.
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Student response regarding Hep B
preventability

Graph D
Q: Based on your knowledge, is Hepatitis B a preventable disease?

Percentage of students knowledgeable of Hep. B preventability

The graph above depicts the number of students who are aware that hepatitis B is
a preventable disease. Ninety students (74.4%) reported hepatitis B is a preventable
disease, six students (4.96%) reported hepatitis B was not a preventable disease, and
twenty-five students (20.66%) reported they were unsure if hepatitis B was preventable.

Student response to beliefs regarding
vaccines

Graph E
Q: Do you believe that vaccines are a safe method to prevent disease(s)?

Percentage of students based on beliefs regarding vaccine use
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The graph above illustrates the belief that vaccines are a safe method to prevent
disease(s). 112 students (92.56%) responded they do believe that vaccines are a safe
method to prevent diseases, four students (3.31%) responded they did not believe
vaccines are a safe method to disease prevention, and five students (4.13%) responded
they were unsure if vaccines were a safe method to disease prevention.

Student responses to beliefs
regarding vaccines

Graph F
Q: Do you believe that vaccines are safe and beneficial to disease prevention?

Percentage of students based on beliefs regarding vaccine safety and benefit to disease
prevention

The graph above depicts the belief that vaccines are safe and beneficial to disease
prevention. One hundred and eleven students (91.74%) responded they believe vaccines
are a safe and beneficial to disease prevention, four students (3.31%) responded they do
not believe vaccines are safe and beneficial to disease prevention, and six students
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(4.96%) responded they were unsure if vaccines are safe and beneficial to disease
prevention.

Percentage of students based on belief regarding
parental decisions to vaccinate children

Graph G
Q: Do you believe parents should vaccinate their child/children?

Student responses to beliefs regarding parental decision to
vaccinate children

The graph above illustrates students’ belief that parents should vaccinate their
child/children. 115 students (95.83%) reported they believe parents should vaccinate
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their children. Three students reported they do not believe parents should vaccinate their
children, and two students preferred not to answer.

Student responses to vaccinating
their current or future children

Graph H
Q: As a parent, would you vaccinate your child/children?

Percentage of students based on willingness to vaccinate
their current or future children
The graph above illustrates whether or not a student would vaccinate his or her
child/children.
115 students (95.04%) responded they would vaccinate their child/children, two students
(1.65%) reported they would not vaccinate their child/children, and four students (3.31%)
reported that they preferred not to answer.
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Table 1A
Hepatitis B familiarity based on classification
Q: Are you familiar with Hepatitis B?
Sample
proportions
.4000000

Classification
Freshman
Sophomore

No
6.0
14.0

Yes
9.0
12.0

Junior
Senior
Graduate
Student
(in pursuit of
Masters or
Ph.D.)

8.0
11.0

22.0
21.0

.5384615
.2666667
.3437500

3.0

15.0

.1666667

[Weighted col %
(95%CI)]
(.1520774-.6479226)
(.3468372-.7300859)
(.1084215-.4249119)
(.1791851-.5083149)

(-.00501784.338835117)

The two- way classification table above reports hepatitis B familiarity based on
classification. The total sample consisted of fifteen freshmen, (12.40%), twenty-six
sophomores (21.49%), thirty juniors (24.48%), thirty-two seniors (26.44%), and eighteen
graduate students (14.88%). Of the fifteen students classified as freshman, six (40%)
reported that they were not familiar with hepatitis B and nine (60%) reported that they
were familiar with hepatitis B. Of the twenty-six students classified as sophomores,
fourteen (53.8%) reported that they were not familiar with hepatitis and twelve (46.2%)
reported that they were familiar with hepatitis B. Of the thirty students classified as
juniors, eight (26.7%) responded they were not familiar with hepatitis B and twenty-two
(73.3%) reported they were familiar with hepatitis B. Of the thirty-three students
classified as seniors, eleven (34.4%) reported they were not familiar with hepatitis B and
twenty-one (65.6%) reported they were familiar with hepatitis B. Lastly, of the eighteen
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students classified as graduate students, three (16.7%) responded they were unfamiliar
with hepatitis B and fifteen (83.3%) reported they were familiar with hepatitis B.
Table 1B (Data)
* 10% significance level with a p-value =.098
x-squared
7.8303

df
4.0

p -value
.098

Using a five sample test for equality of proportions without continuity correction
at a 10% significance level, the p-value of .098 illustrates that the proportion of students
familiar with hepatitis B differs by classification.

Table 2A
Hepatitis B familiarity based on gender

Gender

No

Yes

Sample
proportion

[Weighted col %
(95%CI)]

Female
Male

27.0
15.0

57.0
21.0

0.3214286
0.4166667

(-.3045798-.1141036)

The two-way classification table above reports hepatitis B familiarity based on
gender using a two sample test. The total sample consisted of thirty-six males (30%) and
eighty-four females (70.00%). Of the thirty-six male participants, fifteen (41.7%)
reported they were not familiar with hepatitis B and twenty-one (58.3%) reported they
were. Of the eighty-four female participants, twenty-seven (32.1%) reported they were
unfamiliar with hepatitis B and fifty-seven (67.9%) reported they were familiar with
hepatitis.
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Table 2B (Data)
x-squared
0.62960

df
1.0

p-value
.4275

A 2-sample test for equality of proportions with continuity correction recorded a
p-value of .4275, which indicates that gender is not a significant factor on the influence
of hepatitis B familiarity.

Table 3A
Hepatitis B Familiarity based on major (science vs. non-science)
Major

No

Yes

Sample
Proportions

Non-Science
Science

18.0
24.0

25.0
54.0

0.4186047
0.3076923

[Weighted col
% (95%CI)]
(-0.05779725 1.00000000)

The two-way classification table above reports hepatitis B familiarity based on
majors. The total sample consisted of eighty participants (65.04%) with science or
applied science majors and forty-three participants (34.96%) with non-science majors. Of
the forty-three non-science majors, eighteen (41.9%) were unfamiliar of hepatitis B and
twenty-five (58.1%) were familiar with hepatitis B. Of the eighty students with science or
applied science majors, twenty-four (30.8%) were unfamiliar with hepatitis B and fiftyfour (69.1%) were familiar with hepatitis B.
Table 3B (Data)
x-squared
1.055

df
1.0

p-value
.1522
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A two-sample test for equality of proportions with continuity correction recorded
a p-value of .1522, which illustrates some evidence that science majors may be more
knowledgeable of hepatitis B, but there is no significance.

Table 4
Beliefs regarding vaccine safety and benefit(s) to disease prevention based on
classification
Q: Do you believe that vaccines are safe and beneficial to disease prevention?
Classification

Yes

No

I am not sure

p-value

Freshman
Sophomore

14.0

1.0

0.0

.9472

25.0
25.0
29.0

1.0
1.0
1.0

0.0
4.0
2.0

18.0

0.0

0.0

Junior
Senior
Graduate Student (in
pursuit of Masters or
Ph.D.)

The two- way classification table above reports beliefs regarding vaccine safety
and benefit(s) to disease prevention based on classification. The total sample consisted of
fifteen freshmen, (13.01%), twenty-six sophomores (21.14%), thirty juniors (24.39%),
thirty-three seniors (26.83%), and eighteen graduate students (14.63%). Of the fifteen
freshman respondents, fourteen (93.4%) believed that vaccines are safe and beneficial to
disease prevention, 1(6.6%) did not believe vaccines are safe and beneficial to disease
prevention, and zero (0%) were unsure of their belief. Of the twenty-six students
classified as sophomores, twenty-five (96.2%) believed that vaccines are safe and
beneficial to disease prevention, one (3.8%) did not believe vaccines are safe and

38

beneficial to disease prevention, and zero (0%) were unsure of their belief. Of the thirty
students classified as juniors, twenty-five (83.3%) believed that vaccines were safe and
beneficial to disease prevention, one (3.3%) did not believe vaccines were safe and
beneficial to disease prevention, and four (13.3%) were unsure of their belief.
Of the thirty-three students classified as seniors, twenty-nine (90.6%) believed that
vaccines are safe and beneficial to disease prevention, one (3.1%) did not believe
vaccines were safe and beneficial to disease prevention, and two (6.3%) were unsure of
their beliefs. Lastly, of the eighteen students classified as graduate students, eighteen
students (100%) believed that vaccines are safe and beneficial to disease prevention, zero
students (0.0%) did not believe vaccines are safe and beneficial to disease prevention,
and zero students (11.1%) were unsure of their belief.

Based on the p-value (.9472) determined by the fisher’s exact test, classification is
an important factor for beliefs on vaccine safety and benefit to disease prevention.
Table 5A
Beliefs regarding vaccine safety and benefit(s) to disease prevention based on gender

Gender
Female

Yes
75.0

No
4.0

Male

35.0

0.0

Sample
I am not sure Proportions
5.0
1.0

0.9493671
1.00000

[Weighted
col %
(95%CI)]
(-.11959458.01832876)

The- two-way classification table above reports beliefs regarding vaccine safety
and benefit(s) to disease prevention based on gender. The total sample consisted of 36
males (29.27%) and 86 females (69.92%). Of the eight-four females who responded to
this question, seventy-five (89.3%) believed vaccines are safe and beneficial to disease
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prevent, four (4.8%) did not believe vaccines are safe and beneficial to disease
prevention, and five (5.9%) were unsure of their beliefs. Of the thirty-six male
participants, sixteen (97.2%) believed vaccines are safe and beneficial to disease
prevention, zero (0%) did not believe vaccines are safe and beneficial to disease
prevention, and one (2.8%) were unsure of their belief.
Beliefs regarding vaccine safety and benefit(s) to disease prevention based on gender
Table 5B (Data)
x-squared
0.64553

df
1.0

p-value
.4217

Based on the p-value (.4217) determined by a two-sample test for equality of
proportions with continuity correction, gender is not a factor for beliefs regarding vaccine
safety and benefit(s) to disease prevention.

Table 6A
Beliefs regarding vaccine safety and benefit(s) to disease prevention based on major

Major
Non-science

Yes
37.0

No
1.0

I am not
sure
5.0

Science

74.0

3.0

1.0

Sample
proportions
0.9736842
0.9610390

[Weighted
col %
(95%CI)]
-0.066770370.09206087

Of the forty-three students with non-science majors, thirty-seven (86.0%)
believed that vaccines are safe and beneficial to disease prevention, one (14.0%) did not
believe vaccines are safe and beneficial to disease prevention, and five (11.6%) were
unsure of their belief. Of the seventy-eight students with science majors seventy-four
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(94.8%) believe that vaccines are safe and beneficial to disease prevention, three (3.8%)
did not believe vaccines are safe and beneficial, and one (1.3%) were unsure of their
beliefs.
Table 6B Data
x-squared
2.7246𝑒 !!"

df
1.0

p-value
1.0

Based on the p-value of .9788, determined by a 2-sample test for equality of
proportions with continuity correction, majoring in science/ applied science or nonscience is not a factor in beliefs regarding vaccine safety and benefits (s) to disease
prevention.
Discussion:
Considering the 1995 ACCIP recommendations and the University of
Mississippi’s current vaccine requirements, the final results of the study are
difficult to explain. Potential explanations for the findings of this study are; (a) the
distribution of vaccines generally occurs during early childhood/ infancy, so
students may be unaware of their vaccination status (b) the presence of a deficit in
educational efforts to increase awareness of vaccine use, hepatitis B, and other
preventable diseases (c) the presence and strength of various social stigmas
regarding hepatitis B infection, hepatitis B transmission, and vaccine use limits
their discussion (d) the presence of an age gap limiting the opportunity to witness
the effects of preventable diseases prior to the creation and wide spread
distribution of vaccines (e) a lack of a clear incentive associated with the
knowledge and awareness of hepatitis B and vaccine use among University of
Mississippi students and (f) the strength of the beliefs in which an individual uses
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to identify his/herself. Although the population of this study was comprised of
non-high risk college students, the results illustrate the influence of educational,
social, and environmental factors on the knowledge and awareness of hepatitis B
and vaccine use as a safe preventative measure- even among educated individuals.
An influx of educated individuals that are unaware of hepatitis B and vaccine use
as preventative measure for deadly infectious microbes poses a threat to current
eradication of preventable infectious diseases. Thus, it is reasonable to develop
strategies that incorporate education of hepatitis B, hepatitis B transmission, and
vaccine safety and use, while also working to minimize the effects of social
scrutiny.
Conclusion
As seen in other parts of the world, once an infectious disease is
introduced to a non-vaccinated population it could spread very rapidly.” (Flag
Wars). An increase in the number of U.S. parents and educated individual
expressing opposition to vaccinations against Hepatitis B and other infectious
diseases poses a significant threat of the re-introduction of infectious diseases
among non-vaccinated populations. A lack of knowledge and awareness of
hepatitis B infection and transmission and vaccine use among highly educated
students indicates the need for the implementation of specific educational
programs at the University of MS directed towards; (a) increasing knowledge and
awareness of preventable diseases, such as hepatitis B, (b) minimizing social
stigmas associated with these topics, and (c) encouraging and increasing the use
of strong educational backgrounds, specifically in science related subjects, to
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motivate others to consider the risk side of infectious diseases even when the
symptoms are not visible.
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